1. Home
  2. SPRC vs SXTP Comparison

SPRC vs SXTP Comparison

Compare SPRC & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • SXTP
  • Stock Information
  • Founded
  • SPRC 2004
  • SXTP 2010
  • Country
  • SPRC Israel
  • SXTP United States
  • Employees
  • SPRC N/A
  • SXTP N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • SXTP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • SXTP Health Care
  • Exchange
  • SPRC Nasdaq
  • SXTP Nasdaq
  • Market Cap
  • SPRC 7.3M
  • SXTP 6.7M
  • IPO Year
  • SPRC N/A
  • SXTP 2023
  • Fundamental
  • Price
  • SPRC $4.27
  • SXTP $1.45
  • Analyst Decision
  • SPRC
  • SXTP Buy
  • Analyst Count
  • SPRC 0
  • SXTP 2
  • Target Price
  • SPRC N/A
  • SXTP $3.00
  • AVG Volume (30 Days)
  • SPRC 7.0M
  • SXTP 282.6K
  • Earning Date
  • SPRC 01-01-0001
  • SXTP 11-13-2025
  • Dividend Yield
  • SPRC N/A
  • SXTP N/A
  • EPS Growth
  • SPRC N/A
  • SXTP N/A
  • EPS
  • SPRC N/A
  • SXTP N/A
  • Revenue
  • SPRC $1,306,000.00
  • SXTP $984,494.00
  • Revenue This Year
  • SPRC N/A
  • SXTP $81.41
  • Revenue Next Year
  • SPRC N/A
  • SXTP $83.17
  • P/E Ratio
  • SPRC N/A
  • SXTP N/A
  • Revenue Growth
  • SPRC N/A
  • SXTP 128.70
  • 52 Week Low
  • SPRC $1.75
  • SXTP $1.22
  • 52 Week High
  • SPRC $37.59
  • SXTP $12.45
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 50.89
  • SXTP 47.33
  • Support Level
  • SPRC $3.75
  • SXTP $1.43
  • Resistance Level
  • SPRC $4.48
  • SXTP $1.56
  • Average True Range (ATR)
  • SPRC 0.50
  • SXTP 0.14
  • MACD
  • SPRC -0.06
  • SXTP -0.01
  • Stochastic Oscillator
  • SPRC 38.85
  • SXTP 15.22

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Share on Social Networks: